ImageneBio
(NASDAQ) IMA
ImageneBio Financials at a Glance
Market Cap
$63.64M
Revenue (TTM)
$0.00
Net Income (TTM)
$43.07M
EPS (TTM)
$-6.45
P/E Ratio
-0.88
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$5.79
Volume
5,382
Open
$5.70
Price
$5.79
Volume
5,382
Open
$5.70
Previous Close
$5.79
Daily Range
$5.54 - $5.91
52-Week Range
$5.35 - $18.00
Dividend
$0.00
Beta (Volatility)
1.22 (Average)
Price
$5.79
Volume
5,382
Open
$5.70
Previous Close
$5.79
Daily Range
$5.54 - $5.91
52-Week Range
$5.35 - $18.00
IMA News
IMA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ImageneBio
Industry
Pharmaceuticals
Sector
Health CareEmployees
15
CEO
Kristin Yarema, PhD
Website
www.inmagenebio.comHeadquarters
San Diego, CA 92130, US
IMA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-33%
Return on Capital
-68%
Return on Assets
-52%
Earnings Yield
-1.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$63.64M
Shares Outstanding
11.19M
Volume
5.38K
Short Interest
0.00%
Avg. Volume
43.29K
Financials (TTM)
Gross Profit
$233.00K
Operating Income
$48.45M
EBITDA
$47.42M
Operating Cash Flow
$47.84M
Capital Expenditure
$0.00
Free Cash Flow
$47.84M
Cash & ST Invst.
$75.78M
Total Debt
$9.99M
ImageneBio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$561.00K
+87.8%
Gross Margin
0.00%
N/A
Market Cap
$63.64M
N/A
Market Cap/Employee
$6.36M
N/A
Employees
10
N/A
Net Income
$6.91M
+24.3%
EBITDA
$7.94M
+34.3%
Quarterly Fundamentals
Net Cash
$65.79M
-43.7%
Accounts Receivable
$1.30M
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.73M
+106.9%
Short Term Debt
$2.26M
-40.2%
Return on Assets
-52.02%
N/A
Return on Invested Capital
-67.70%
N/A
Free Cash Flow
$7.22M
-15.3%
Operating Cash Flow
$7.22M
-15.3%